Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113935 | 0.95 | LMNA (0.39) | LMNA | |
| SCHEMBL2720576 | 0.89 | LMNA (0.32) | LMNA | |
| SCHEMBL19098386 | 0.87 | — | — | |
| SCHEMBL12305456 | 0.86 | LMNA (0.42) | LMNA | |
| SCHEMBL11024910 | 0.86 | LMNA (0.47) | LMNA | |
| SCHEMBL9859842 | 0.85 | LMNA (0.41) | LMNA | |
| SCHEMBL14436861 | 0.85 | LMNA (0.36) | LMNA | |
| SCHEMBL15032837 | 0.84 | LMNA (0.50) | LMNA | |
| SCHEMBL12190547 | 0.84 | LMNA (0.33) | LMNA | |
| SCHEMBL12190388 | 0.84 | DYRK3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9957358-B2 | Curable polymers comprising silsesquioxane polymer core silsesquioxane polymer outer layer, and reactive groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-05-01 | — | — | US | disclosed |
| US-9957416-B2 | Curable end-capped silsesquioxane polymer comprising reactive groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170275426-A1 | CURABLE POLYMERS COMPRISING SILSESQUIOXANE POLYMER CORE SILSESQUIOXANE POLYMER OUTER LAYER, AND REACTIVE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2017-09-28 | — | — | US | disclosed |
| US-20170275426-A1 | CURABLE POLYMERS COMPRISING SILSESQUIOXANE POLYMER CORE SILSESQUIOXANE POLYMER OUTER LAYER, AND REACTIVE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY | 2017-09-28 | — | — | US | disclosed |
| US-20170190843-A1 | CURABLE END-CAPPED SILSESQUIOXANE POLYMER COMPRISING REACTIVE GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2017-07-06 | — | — | US | disclosed |
| US-9217921-B2 | Resist underlayer film forming composition containing silicon having sulfide bond | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-22 | — | — | US | disclosed |
| EP-0625176-B1 | MOISTURE CURABLE POLYSILOXANE RELEASE COATING COMPOSITIONS | MINNESOTA MINING & MFG (US) | 1996-12-04 | — | — | EP | disclosed |
| EP-0625176-A1 | MOISTURE CURABLE POLYSILOXANE RELEASE COATING COMPOSITIONS. | MINNESOTA MINING & MFG (US) | 1994-11-23 | — | — | EP | disclosed |
| US-5286815-A | Containing an acid catalyst | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-02-15 | — | — | US | disclosed |
| WO-1993016142-A1 | MOISTURE CURABLE POLYSILOXANE RELEASE COATING COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170190843-A1 | CURABLE END-CAPPED SILSESQUIOXANE POLYMER COMPRISING REACTIVE GROUPS | CAPG, CLSPN, CAPNS1 | LMNA 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.